Yuichi Ikegami

Possible Long-Term Efficacy of Sitagliptin, a Dipeptidyl Peptidase-4 Inhibitor, for Slowly Progressive Type 1 Diabetes (SPIDDM) in the Stage of Non-Insulin-Dependency: An Open-Label Randomized Controlled Pilot Trial (SPAN-S)

Takuya Awata, Akira Shimada, Taro Maruyama et al. · Diabetes Therapy · 2017 · 54 citations · Full text

LKB1, an upstream AMPK kinase, regulates glucose and lipid metabolism in cultured liver and muscle cells

Kenta Imai, Kouichi Inukai, Yuichi Ikegami et al. · Biochemical and Biophysical Research Communications · 2006 · 52 citations

Muscle Cells, Cultured Liver, Signal Transduction +11

Insulin-like growth factor-I ameliorates transient ischemia-induced acute renal failure in rats.

Soichi Noguchi, Yoneo Kashihara, Yuichi Ikegami et al. · Journal of Pharmacology and Experimental Therapeutics · 1993 · 49 citations

The annual rate of coronary artery calcification with combination therapy with a PCSK9 inhibitor and a statin is lower than that with statin monotherapy

Yuichi Ikegami, Ikuo Inoue, Kaiji Inoue et al. · npj Aging and Mechanisms of Disease · 2018 · 49 citations · Full text

Burn-induced muscle metabolic derangements and mitochondrial dysfunction are associated with activation of HIF-1α and mTORC1: Role of protein farnesylation

Harumasa Nakazawa, Kazuhiro Ikeda, Shohei Shinozaki et al. · Scientific Reports · 2017 · 27 citations · Full text